Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Aduro Biotech Q2 EPS $(0.21) Up From $(0.23) YoY, Sales $5.57M Up From $4.89M YoY

Author: Benzinga Newsdesk | August 03, 2020 04:26pm
Aduro Biotech (NASDAQ:ADRO) reported quarterly losses of $(0.21) per share. This is a 8.7 percent increase over losses of $(0.23) per share from the same period last year. The company reported $5.57 million in sales this quarter. This is a 14.03 percent increase over sales of $4.89 million the same period last year.

Posted In: ADRO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist